関連する実験動画
Updated: Sep 10, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.0K
喘息患者における口服用コルチコステロイドの使用の削減に関するスペインのコンセンサスの勧告への遵守度:アンケートに基づく観察研究
Javier Domínguez-Ortega1,2, Xavier Muñoz Gall2,3, Julio Delgado Romero4
1Department of Allergy, Hospital Universitario La Paz, Institute for Health Research (IDIPAZ), Madrid, Spain.
Open respiratory archives
|August 25, 2025
まとめ
保健医療従事者は,喘息の経口用コルチコステロイド (OCS) の使用を減らすためのスペインのコンセンサスの高い認識を示しました. 実施は6ヶ月で改善され,よりよい喘息管理のための効果的な教育介入を示しています.
科学分野:
- 肺科
- アレルギー学
- クリニカル・プラクティスのガイドライン
背景:
- 口服用コルチコステロイド (OCS) の過剰使用は,喘息の管理において重大な懸念事項である.
- OCSの使用の削減を導くためにスペインのコンセンサスが公表されました.
- 医療従事者のこのコンセンサスの認識と実施は評価が必要です.
研究 の 目的:
- 喘息におけるOCSの減少に関するスペインのコンセンサスに対する医療従事者の認識を評価する.
- 合意による勧告の実施と遵守を評価する.
- 薬の処方方法や 臨床医が報告した行動の変化を 特定するためです
主な方法:
- 肺科医とアレルギー専門医を対象とした縦断調査.
- 6ヶ月間隔で2回の調査が行われました.
- 主な指標は,OCSの処方率,コンセンサスの知識,およびガイドラインの遵守でした.
主要な成果:
- このコンセンサスの高い認識 (91.1%) が報告され,58.0%がコンセンサスの高い認識であると評価した.
- 大半は,低用量療法として1日5mgのプレドニゾンを考慮し,年間OCS用量を増加させた.
- 臨床医は,より短いOCSコースを好み,重症で制御不能な喘息の生物学的治療を推奨しました.
結論:
- スペインのコンセンサスの公表により,OCSの使用が減り,ガイドラインの遵守が改善されました.
- 繰り返された教育的な介入は 処方行動に 効果的な変化をもたらしました
- ガイドラインの実施と教育強化を通じて 喘息の治療を最適化することが可能である.
関連する概念動画
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
385
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
385
01:26COPD: Management Using Bronchodilators and Corticosteroids
307
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
307
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:20Asthma: Pathogenesis and Management
581
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
380
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
380
01:19Antiasthma Drugs: Leukotriene Modifiers
463
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
463